Properties
What is it?
Livéo Intimi capsules contain the following complex of lactobacilli: Lactobacillus reuteri (RC-14) and Lactobacillus rhamnosus (GR-1) Livéo Intimi intake increases the natural number of lactobacilli in the vagina. Indications: • Bacterial vaginosis • Vaginal fungal infection • Vaginal dysbacteriosis • During all three trimesters of pregnancy for any type of discharge • Chronic (recurrent) cystitis • Postpartum period • During antibiotic therapy • Post-operative period • Before and after invasive vaginal procedures • During gastrointestinal infections • Irritable bowel syndrome Dosage: • 1-2 capsules per day for 2 weeks. Indicated for ages 12 and above. Each Livéo Intimi capsule contains at least 2 billion (2*10^9) CFU of Lactobacillus reuteri (RC-14) and Lactobacillus rhamnosus (GR-1) Lactobacillus reuteri (RC-14) and Lactobacillus rhamnosus (GR-1) are natural bacteria of the vaginal flora. After intake, Lactobacillus reuteri (RC-14) and Lactobacillus rhamnosus (GR-1) in Livéo Intimi pass through the gastrointestinal tract and migrate from the anus to the vagina. Livéo Intimi capsules are manufactured using special technology that ensures the capsule passes through the small intestine intact, to avoid the negative effects of bile acids and enzymes. Composition: Lactobacillus reuteri (RC-14) and Lactobacillus rhamnosus (GR-1), maltodextrin, microcrystalline cellulose, magnesium salts of fatty acids, hydroxypropyl methylcellulose. Country of manufacture: Latvia. Learn about intimate hygiene in our blog: Intimate Hygiene
